Influence of KRAS mutation status in metachronous and synchronous metastatic colorectal adenocarcinoma.

MLA

Rose, Jeffrey S., et al. “Influence of KRAS Mutation Status in Metachronous and Synchronous Metastatic Colorectal Adenocarcinoma.” Cancer, vol. 118, no. 24, Dec. 2012, pp. 6243–52. EBSCOhost, https://doi.org/10.1002/cncr.27666.

APA

Rose, J. S., Serna, D. S., Martin, L. K., Li, X., Weatherby, L. M., Abdel-Misih, S., Zhao, W., & Bekaii-Saab, T. (2012). Influence of KRAS mutation status in metachronous and synchronous metastatic colorectal adenocarcinoma. Cancer, 118(24), 6243–6252. https://doi.org/10.1002/cncr.27666

Chicago

Rose, Jeffrey S, Derek S Serna, Ludmila Katherine Martin, Xiaobai Li, Lynn M Weatherby, Sherif Abdel-Misih, Weiqiang Zhao, and Tanios Bekaii-Saab. 2012. “Influence of KRAS Mutation Status in Metachronous and Synchronous Metastatic Colorectal Adenocarcinoma.” Cancer 118 (24): 6243–52. doi:10.1002/cncr.27666.